-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AnF9MEbya9OAwvQ33mHeY8mxWVHQQ52MuKR3IOY7WVeqT2YsqD7/wVKhimtpzK4s zQ7/pA/cngoV28a1v43WRg== 0000725058-07-000002.txt : 20070104 0000725058-07-000002.hdr.sgml : 20070104 20070104165315 ACCESSION NUMBER: 0000725058-07-000002 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070101 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20070104 DATE AS OF CHANGE: 20070104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CYTOGEN CORP CENTRAL INDEX KEY: 0000725058 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222322400 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-14879 FILM NUMBER: 07510218 BUSINESS ADDRESS: STREET 1: 650 COLLEGE RD EAST STE 3100 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6099878200 MAIL ADDRESS: STREET 1: 650 COLLEGE RD EAST STE 3100 CITY: PRINCETON STATE: NJ ZIP: 08540 8-K 1 form8k_010407.txt FORM 8-K COMPENSATION 010407 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------------------------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 1, 2007 --------------- CYTOGEN CORPORATION ------------------------------------------------ (Exact Name of Registrant as Specified in Charter) Delaware 000-14879 22-2322400 - ---------------------------- ------------------------ ------------------- (State or Other Jurisdiction (Commission File Number) (I.R.S. Employer of Incorporation) Identification No.) 650 College Road East, CN 5308, Suite 3100, Princeton, NJ 08540 - --------------------------------------------------------- ------------------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (609) 750-8200 -------------- - -------------------------------------------------------------------------------- (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers. In connection with its annual performance review process, the Compensation Committee and the Board of Directors of Cytogen Corporation (the "Company") approved, as of January 1, 2007, the annual incentive (i.e. cash bonus) awards for the period January 1, 2006 to December 31, 2006 and the annual salaries for 2007 for executive officers of the Company. The annual incentive awards, as shown in the table below, were based on the Compensation Committee's assessment of the Company's and each executive's performance measured against previously set financial and strategic objectives. The following table sets forth the cash bonus amounts for 2006 performance and the annual base salaries for 2007 for the executive officers (Michael D. Becker, Kevin J. Bratton, William F. Goeckeler, and William J. Thomas) who will be included as the Named Executive Officers in the Company's 2007 proxy statement. - -------------------------------------------------------------------------------- NAME TITLE 2006 BONUS 2007 SALARY - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- Michael D. Becker President and Chief $160,808 $383,720 Executive Officer - -------------------------------------------------------------------------------- Kevin J. Bratton Senior Vice President, $ 20,000 $225,000 Finance, and Chief Financial Officer - -------------------------------------------------------------------------------- William F. Goeckeler Senior Vice President, $ 91,664 $277,156 Operations - -------------------------------------------------------------------------------- William J. Thomas Senior Vice President and $ 66,338 $253,386 General Counsel - -------------------------------------------------------------------------------- The Named Executive Officers do not currently have any employment agreements with the Company. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CYTOGEN CORPORATION By: /s/ William J. Thomas ---------------------------- William J. Thomas Senior Vice President and General Counsel Dated: January 4, 2007 -----END PRIVACY-ENHANCED MESSAGE-----